Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: Jeffrey L. Henken who wrote (1363)	6/26/1998 2:42:00 PM
From: Ray Tarke	Read Replies (1) \| Respond to of 2887

Jeff, We should be hearing news on two wonderful products, with a strong worldwide annual market. americanbiomed.com FDA marketing approval of its 100% silicone-based bi-lumen balloon infusion catheters for thrombectomy and thrombolysis. The application includes four variations of the bi-lumen catheter presently being marketed, each differentiated by the placement of balloons on the catheter. Should happen anytime now ! American BioMed Guidewire Microfilter a Great Product !! fast.quote.com The OmniFilter, a percutaneous guidewire microfilter that converts a standard guidewire into a temporary microemboli filter, is designed to prevent stroke-causing blood clots from reaching various organs of the body. Its patented "purse string" closure secures clot removal without loss into the blood stream, and its cost-effective design reduces the chance of stroke and prevents distal embolization. American BioMed's Principal Clinical Investigator, Dr. Samuel S. Ahn, stated, "Surgeons and interventionalists need guidewire microfilter technology to prevent strokes that may occur during carotid balloon angioplasty procedures. American BioMed's OmniFilter may provide an important solution." Industry analysts estimate a $500 million annual worldwide market for carotid angioplasty applications using this technology, with the U.S. representing approximately one-half of the worldwide market. The giants in the medical field would love to have a product such as Guidewire Microfilter in there arsenal. I can't wait to hear further developments ! Should be around the Corner. Regards, R.T